News
Johnson & Johnson Expands Oncology Portfolio with $1 Billion Firefly Bio Deal
Firefly Bio’s Firelink DAC platform will help advance Johnson & Johnson’s strategy to develop targeted therapies for some of the most prevalent and difficult-to-treat solid tumours.


